Amoxicillin and Clavulanate Potassium
These highlights do not include all the information needed to use Amoxicillin and Clavulanate Potassium Extended Release Tablets safely and effectively. See full prescribing information for Amoxicillin and Clavulanate Potassium Extended Release Tablets Amoxicillin and Clavulanate Potassium Extended Release Tablets Initial U.S. Approval: 2002 To reduce the development of drug-resistant bacteria and maintain the effectiveness of Amoxicillin and Clavulanate Potassium Extended Release Tablets and other antibacterial drugs, Amoxicillin and Clavulanate Potassium Extended Release Tablets should be used only to treat infections that are proven or strongly suspected to be caused by susceptible bacteria.(1)
fc4bb4b0-9330-4701-a600-199c42fb3255
HUMAN PRESCRIPTION DRUG LABEL
Jan 17, 2014
Dr. Reddy's Laboratories Inc
DUNS: 802315887
Products 1
Detailed information about drug products covered under this FDA approval, including NDC codes, dosage forms, ingredients, and administration routes.
amoxicillin and clavulanate potassium
Product Details
FDA regulatory identification and product classification information